<p>(p<0.05: *compared with h, **compared with s, ***compared with ss.); h: healthy controls; s: sepsis; ss: severe sepsis; sh: septic shock.</p
Objectives: Biomarkers are widely used for rapid diagnosis of sepsis. This study evaluated the diagn...
The goal of our study is to assess the diagnostic profi tability of procalcitonin (PCT) in septic sh...
<p>A. Septic patients had lower pGSN levels compared to normal controls (p = 0.01). B. Septic patien...
<p>*compared with healthy controls, P<0.01; # compared with the sepsis group, P<0.05. H: healthy con...
<p>Serum concentrations of biomarkers in patients with severe sepsis/septic shock and healthy contro...
<p>i. Others (i.e., non-verified bacterial infection, viral infection, and no infection) (<i>n</i> =...
<p>Comparisons of plasma biomarkers between survivors and nonsurvivors of severe sepsis and septic s...
<p>Data are shown as mean + SEM and analyzed by one-way ANOVA followed by Dunnett’s post hoc test.</...
OBJECTIVE: To compare the clinical informative value of procalcitonin (PCT) and C-reactive protein ...
a<p>P value of sepsis group compare with intracranial infection group; <sup>b</sup>P value of sepsis...
<p>Box and whisker plots displaying distribution of 9 APR biomarkers (SAA, CRP, Hp, ferritin, SAP, P...
The horizontal bars represent the median, the boxes represent the IQR, and the vertical bars represe...
<p>(a) sBTLA concentrations in the sepsis cohort (median 14 ng/mL, IQR 8–29), ICU controls (median 9...
The goal of our study is to assess the diagnostic profi tability of procalcitonin (PCT) in septic sh...
Objectives: Biomarkers are widely used for rapid diagnosis of sepsis. This study evaluated the diagn...
Objectives: Biomarkers are widely used for rapid diagnosis of sepsis. This study evaluated the diagn...
The goal of our study is to assess the diagnostic profi tability of procalcitonin (PCT) in septic sh...
<p>A. Septic patients had lower pGSN levels compared to normal controls (p = 0.01). B. Septic patien...
<p>*compared with healthy controls, P<0.01; # compared with the sepsis group, P<0.05. H: healthy con...
<p>Serum concentrations of biomarkers in patients with severe sepsis/septic shock and healthy contro...
<p>i. Others (i.e., non-verified bacterial infection, viral infection, and no infection) (<i>n</i> =...
<p>Comparisons of plasma biomarkers between survivors and nonsurvivors of severe sepsis and septic s...
<p>Data are shown as mean + SEM and analyzed by one-way ANOVA followed by Dunnett’s post hoc test.</...
OBJECTIVE: To compare the clinical informative value of procalcitonin (PCT) and C-reactive protein ...
a<p>P value of sepsis group compare with intracranial infection group; <sup>b</sup>P value of sepsis...
<p>Box and whisker plots displaying distribution of 9 APR biomarkers (SAA, CRP, Hp, ferritin, SAP, P...
The horizontal bars represent the median, the boxes represent the IQR, and the vertical bars represe...
<p>(a) sBTLA concentrations in the sepsis cohort (median 14 ng/mL, IQR 8–29), ICU controls (median 9...
The goal of our study is to assess the diagnostic profi tability of procalcitonin (PCT) in septic sh...
Objectives: Biomarkers are widely used for rapid diagnosis of sepsis. This study evaluated the diagn...
Objectives: Biomarkers are widely used for rapid diagnosis of sepsis. This study evaluated the diagn...
The goal of our study is to assess the diagnostic profi tability of procalcitonin (PCT) in septic sh...
<p>A. Septic patients had lower pGSN levels compared to normal controls (p = 0.01). B. Septic patien...
DOI
Add to ORKG